News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New Leaf Venture Partners Announces $12 Million Financing In Tioga Pharmaceuticals


1/10/2006 10:56:47 AM

NEW YORK & MENLO PARK, Calif.--(BUSINESS WIRE)--Jan. 9, 2006--New Leaf Venture Partners (NLV Partners) announced today that it has invested in a $24 million Series A private equity financing in Tioga Pharmaceuticals Incorporated. Tioga Pharmaceuticals is engaged in the development of novel therapies for the treatment of gastrointestinal diseases. Tioga is developing asimadoline, a proprietary small molecule, for treating irritable bowel syndrome (IBS) and post operative ileus. NLV invested $12 million in the Series A financing, which was led by Forward Ventures. BB Biotech Ventures II also participated in the financing. The capital will be used to fund a 600 patient phase IIb clinical trial for irritable bowel syndrome and a 130 patient phase IIa trial for post operative ileus.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES